(Q48360646)

English

The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy

scientific article published on 27 September 2012

The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

atrial fibrillation

0 references

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

John W. Eikelboom

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

Olga Shestakovska

object named as

Olga Shestakovska

7

0 references

5

object named as

Gregory Y H Lip

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

4

object named as

Salim Yusuf

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

6

object named as

Paul Dorian

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

Michiel Coppens

1

object named as

Michiel Coppens

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

author name string

Robert G Hart

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

Stuart J Connolly

8

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

publication date

27 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

34

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

170-176

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Apixaban in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS314

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHS314

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

release_spa5mipr25bmlb2wsflwqxbf3y

1 reference

https://api.fatcat.wiki/v0/release/spa5mipr25bmlb2wsflwqxbf3y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23018151

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48360646&oldid=2195840301"